The revival of aztreonam in combination with avibactam against metallo-β-lactamase-producing Gram-negatives: a systematic review of in vitro studies and clinical …

C Mauri, AE Maraolo, S Di Bella, F Luzzaro, L Principe - Antibiotics, 2021 - mdpi.com
Infections caused by metallo-β-lactamase (MBL)-producing Enterobacterales and
Pseudomonas are increasingly reported worldwide and are usually associated with high …

Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli

M Zeng, J Xia, Z Zong, Y Shi, Y Ni, F Hu, Y Chen… - Journal of Microbiology …, 2023 - Elsevier
The dissemination of carbapenem-resistant Gram-negative bacilli (CRGNB) is a global
public health issue. CRGNB isolates are usually extensively drug-resistant or pandrug …

Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions

K Tompkins, D van Duin - European Journal of Clinical Microbiology & …, 2021 - Springer
Carbapenem-resistant Enterobacterales (CRE) are a growing threat to human health
worldwide. CRE often carry multiple resistance genes that limit treatment options and …

New perspectives on antimicrobial agents: imipenem-relebactam

JN O'Donnell, TP Lodise - Antimicrobial Agents and …, 2022 - Am Soc Microbiol
ABSTRACT Imipenem (IMI)/cilastatin/relebactam (REL)(I/R) is a novel β-lactam/β-lactamase
inhibitor combination with expanded microbiologic activity against carbapenem-resistant …

The role of ACT and FOX genes in Klebsiella pneumoniae strains isolated from hospitalized patients

S Amraei, G Eslami, A Taherpour… - Micro Nano Bio …, 2022 - mnba-journal.com
Klebsiella pneumoniae as a main opportunistic pathogen is a common cause of health-care-
associated bacterial infections, which has shown high levels of drug resistance specifically …

Novel antimicrobial agents for gram-negative pathogens

M Karvouniaris, MP Almyroudi, MH Abdul-Aziz, S Blot… - Antibiotics, 2023 - mdpi.com
Gram-negative bacterial resistance to antimicrobials has had an exponential increase at a
global level during the last decades and represent an everyday challenge, especially for the …

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae

P Mantzana, E Protonotariou, A Kassomenaki… - Antibiotics, 2023 - mdpi.com
Polymyxins are commonly used as the last resort for the treatment of MDR Acinetobacter
baumannii and Klebsiella pneumoniae nosocomial infections; however, apart from the …

Epidemiology, mechanisms of resistance and treatment algorithm for infections due to carbapenem-resistant gram-negative bacteria: an expert panel opinion

N Coppola, AE Maraolo, L Onorato, R Scotto, F Calò… - Antibiotics, 2022 - mdpi.com
Antimicrobial resistance represents a serious threat for global health, causing an
unacceptable burden in terms of morbidity, mortality and healthcare costs. In particular, in …

Severe infections caused by difficult-to-treat Gram-negative bacteria

S Dettori, F Portunato, A Vena… - Current Opinion in …, 2023 - journals.lww.com
Severe infections caused by DTR-GNB pose a formidable challenge for healthcare
providers and represent a growing global health issue. The proper administration and …

Metallo-beta-lactamases: Mechanisms, treatment challenges, and future prospects

J Zakhour, LEW El Ayoubi, SS Kanj - Expert review of anti-infective …, 2024 - Taylor & Francis
ABSTRACT Introduction Metallo-beta-lactamases (MBLs) are responsible for resistance to
almost all beta-lactam antibiotics. Found predominantly in Gram-negative bacteria, they …